Trials / Conditions / Diabetic Neuropathic Pain

Diabetic Neuropathic Pain

16 registered clinical trials studyying Diabetic Neuropathic Pain — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, a NCT05406219	Bayer	Phase 1
Completed	A Study to Learn How Safe the Study Treatment BAY2395840 is, How it Affects the Body and How it Moves Into, Th NCT05563454	Bayer	Phase 1
Completed	Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid o NCT04471337	Bayer	Phase 1
Completed	A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Par NCT04487431	Bayer	Phase 1
Completed	Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid NCT04454424	Bayer	Phase 1
Completed	Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug NCT04265781	Bayer	Phase 1
Recruiting	A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Ch NCT05986292	Eli Lilly and Company	Phase 2
Unknown	Clinical Study on the Improvement of Diabetic Neuropathic Pain by Liraglutide NCT04137328	Fudan University	N/A
Completed	the Effectiveness of Intermittent Pneumatic Compression on Neuropathic Pain in Patients With Diabetic Polyneur NCT06336486	Busra Gunes	N/A
Terminated	A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain NCT01579279	AbbVie (prior sponsor, Abbott)	Phase 2
Completed	A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on NCT01589432	AbbVie (prior sponsor, Abbott)	Phase 2
Completed	A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With NCT01345045	AbbVie (prior sponsor, Abbott)	Phase 2
Terminated	Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy NCT00619983	Wake Forest University	Phase 4
Completed	A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain NCT00548925	AbbVie (prior sponsor, Abbott)	Phase 2
Completed	Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain NCT00452777	Swedish Orphan Biovitrum	Phase 2
Completed	Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee) NCT02783469	University of Dundee	—